Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced key changes in its leadership team, with Ms. Fung Wai Sum resigning from her roles and Mr. Chung Ming Fai stepping in as the new Joint Company Secretary and Authorized Representative, effective January 1, 2025. This leadership transition may impact the company’s operational dynamics as it continues to navigate its strategic goals.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.